The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsDonald S. Silverberg, Adrian Iaina, David Brosh et al.|Journal of the American College of Cardiology|2000Cited by 729